Follow
Karl-Erik Andersson
Karl-Erik Andersson
Professor, Wake Forest University
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Scandinavian Simvastatin Survival Study Group
The Lancet 344 (8934), 1383-1389, 1994
108951994
Physiology of penile erection
KE Andersson, G Wagner
Physiological reviews 75 (1), 191-236, 1995
15711995
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ …
P Abrams, KE Andersson, L Birder, L Brubaker, L Cardozo, C Chapple, ...
Neurourol Urodyn 29 (1), 213-40, 2010
15152010
Urinary bladder contraction and relaxation: physiology and pathophysiology
KE Andersson, A Arner
Physiological reviews 84 (3), 935-986, 2004
12062004
Pharmacology of the lower urinary tract
KE Andersson, C Gratzke
Textbook of the neurogenic bladder, 95-114, 2008
10132008
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
P Abrams, KE Andersson, JJ Buccafusco, C Chapple, WC De Groat, ...
British journal of pharmacology 148 (5), 565-578, 2006
6942006
Pharmacology of penile erection
KE Andersson
Pharmacological reviews 53 (3), 417-450, 2001
6932001
Defective smooth muscle regulation in cGMP kinase I‐deficient mice
A Pfeifer, P Klatt, S Massberg, L Ny, M Sausbier, C Hirneiß, GX Wang, ...
The EMBO journal, 1998
6621998
EAU guidelines on urinary incontinence
JW Thüroff, P Abrams, KE Andersson, W Artibani, CR Chapple, MJ Drake, ...
Actas Urológicas Españolas (English Edition) 35 (7), 373-388, 2011
6172011
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence
KE Andersson, AJ Wein
Pharmacological reviews 56 (4), 581-631, 2004
6012004
The pharmacological treatment of urinary incontinence
KE Andersson, R Appell, LD Cardozo, C Chapple, HP Drutz, ...
BJU international 84, 923-947, 1999
5901999
Antimuscarinics for treatment of overactive bladder
KE Andersson
The Lancet Neurology 3 (1), 46-53, 2004
5642004
Summary of the recommendations on sexual dysfunctions in men
TF Lue, F Giuliano, F Montorsi, RC Rosen, KE Andersson, S Althof, ...
The journal of sexual medicine 1 (1), 6-23, 2004
5472004
Anatomy, physiology, and pathophysiology of erectile dysfunction
C Gratzke, J Angulo, K Chitaley, Y Dai, NN Kim, JS Paick, U Simonsen, ...
The journal of sexual medicine 7 (1_Part_2), 445-475, 2010
5122010
Muscarinic receptor antagonists for overactive bladder
P Abrams, KE Andersson
BJU international 100 (5), 987-1006, 2007
5092007
Urothelial signaling
L Birder, KE Andersson
Physiological reviews 93 (2), 653-680, 2013
5062013
Bladder activation: afferent mechanisms
KE Andersson
Urology 59 (5), 43-50, 2002
4872002
Summary of the recommendations on sexual dysfunctions in men
F Montorsi, G Adaikan, E Becher, F Giuliano, S Khoury, TF Lue, I Sharlip, ...
The journal of sexual medicine 7 (11), 3572-3588, 2010
4652010
Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels
ED Högestätt, KE Andersson, L Edvinsson
Acta Physiologica Scandinavica 117 (1), 49-61, 1983
4491983
The vasodilator‐stimulated phosphoprotein (VASP) is involved in cGMP‐and cAMP‐mediated inhibition of agonist‐induced platelet aggregation, but is dispensable for smooth muscle …
A Aszodi, A Pfeifer, M Ahmad, M Glauner, XH Zhou, L Ny, KE Andersson, ...
The EMBO journal, 1999
4451999
The system can't perform the operation now. Try again later.
Articles 1–20